Newsletter | August 6, 2026

08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build

FEATURED EVENT

ISPOR Healthcare Investment Summit 2026

Biopharma investing today demands more than breakthrough science. Policy, pricing, reimbursement, and health economics increasingly shape a product’s value long before it reaches the market. Join investors, innovators, policy makers, and value leaders at the ISPOR Healthcare Investment Summit to gain insights that drive smarter, more resilient investment decisions.

EDITOR’S NOTE

Inside Versiti’s AI-Ready Data Strategy

Versiti’s Banu Santebennur explains how clean data, semantic layers, and measured tech adoption prepare research for AI.

OPERATIONAL INSIGHTS

Data Quality And Monitoring In Clinical Trials

Clear data ownership and tailored reporting reduce errors and manual reconciliation, keeping trials accurate and audit-ready.

The AI Connectors That Matter In Clinical Development

Explore how modular agents, connectors, and frameworks support scalable, interoperable trial automation.

Building An AI Governance Framework For Clinical Research

Structured oversight, transparency, and collaboration help ensure compliance, reduce bias, and build trust in data-driven trials.

Faster Study Build With Human-AI Collaboration

Combining human expertise with AI can improve speed, consistency, and oversight while catching issues earlier.

How AI Can Speed Trial And Registry Builds

AI tools automate complex tasks and generate intelligent data while preserving control, accuracy, and flexibility.

Flexible Support For Early-Phase Oncology Trials

Shifting cohorts, doses, and protocols challenge early-phase trials. Adaptable technology helps keep studies on track.

SOLUTIONS SPOTLIGHT

Central eSource: Leveraging Site Technology

Judi Core: Pre-Configured Solutions